# Cardiovascular Risk in T2DM With MAFLD: A Cohort Study

> **NCT07706010** · — · NOT_YET_RECRUITING · sponsor: **The Affiliated Hospital of Hangzhou Normal University** · enrollment: 7000 (estimated)

## Conditions studied

- Type 2 Diabetes (T2DM)
- Metabolic Dysfunction-Associated Steatotic Liver Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07706010
- **Lead sponsor:** The Affiliated Hospital of Hangzhou Normal University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-12
- **Primary completion:** 2028-05-29
- **Final completion:** 2031-05-29
- **Target enrollment:** 7000 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706010, "Cardiovascular Risk in T2DM With MAFLD: A Cohort Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07706010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*